Anal Cancer

When you’re a patient at Providence, we don’t just treat your anal cancer – we treat you. We use the most advanced treatments to create a highly personalized care plan. We also support you and your loved ones with a full range of services throughout your entire cancer journey. The result is effective, whole-person care for the body, mind and spirit.

Why Choose Us for Anal Cancer Care?

At Providence, we see the life in you. Together, let’s finish cancer – so you don’t have to miss any of life’s special moments.

No two patients, or their treatment plans, are alike. This is why, at Providence, we take a highly personalized approach to your anal cancer care. You’ll experience this through our multidisciplinary tumor boards, where your oncology team collaborates with other cancer care experts about your specific diagnosis. We also offer a Providence Molecular Tumor Board, where we evaluate your genomic and clinical information to find the best genetically matched treatment for you. Your oncology team will work with you directly to design a treatment plan that fits your personal needs. It’s an approach that combines leading-edge treatment with the compassionate care Providence is known for. Why? Because we know this results in the best outcomes.

As a patient, you’ll be supported through your entire cancer journey by a multidisciplinary cancer care team. You’ll be treated by board-certified medical oncologists and gastroenterologists. Our gynecologists and urologists may also work with you to preserve fertility and sexual function. If surgery is required, our world-class colorectal surgeons use the most advanced techniques to provide you with the best outcomes. It’s a team-based approach to anal cancer care. Your care team may include oncology nurse navigators, ostomy nurses and other cancer specialists. We also provide you and your family with a full range of support services well beyond conventional treatment, from genetic counseling and education to nutrition and pain management.

Learn more about the experts who make up our multidisciplinary cancer care teams.

Cancer doesn’t discriminate, but access to great anal cancer care hasn’t always been the same for everyone. At Providence, we are deeply committed to making sure every patient we treat has access to the best cancer care. We offer various location-specific services to help our patients receive equitable care, such as translation for non-English-speaking patients, telehealth and transportation assistance. We value, respect and support the racial, ethnic, religious, gender, sexual and spiritual identities of each member of our diverse communities, and we welcome all patients, regardless of their ability to pay. We aim to make sure every patient is treated equally and with dignity – whoever you are, and wherever you’re at.

As a patient at Providence, you have access to the largest community-based cancer network in the United States. Being part of a collaborative network means that your local anal cancer care team shares knowledge and experience with other world-class clinicians across 51 hospitals in seven states. The extent and power of our network is one of the reasons more than 7,500 new gastrointestinal cancer patients, and 50,000 new cancer patients, choose Providence each year.

Providence is well known for offering options – and hope – to patients seeking the most advanced procedures and therapies to treat anal cancer. Our research oncologists are currently testing the effectiveness of immunotherapy drugs in combination with chemotherapy to stop tumor growth. As a patient, you have the opportunity to participate in one of approximately 70 clinical trials for gastrointestinal cancers happening across the Providence network.

About Anal Cancer

Anal cancer is a form of gastrointestinal cancer that occurs when cancer cells form in the anus or anal canal. It is more common in people over 50 but can occur at any age. The expert oncology teams at Providence use the most effective therapies to treat patients with every type of anal cancer and its related conditions.

Testing and Diagnostics

pathologist looks through microscope at a sample

Diagnostic tools help our cancer clinicians determine which therapies will work best for each patient, based on many factors such as cancer type and the genetic or molecular profile of the tumor. Your doctors will use multiple advanced diagnostic and prognostic tools to help design your individualized treatment plan. Depending on your case, this may include one or more of the following:

Personalized Treatment for Anal Cancer

We take a team approach to your anal cancer treatment because we know this offers the best success in controlling and curing cancer. Your multidisciplinary cancer care team will work with you to design an individualized cancer care plan, from diagnosis to post-treatment support. We offer many different therapies across our Providence locations. Depending on your condition, your personal care plan may include one or more of the following:

Systemic therapies travel through the bloodstream and affect cells in other body parts. They are used for patients whose cancer has spread to other areas of the body or if there’s a high risk of spread. Sophisticated genetic analysis allows us to target therapies to specific DNA mutations that cause cancer cells to develop and grow. Systemic therapies include:

Biomarker and genomic clinical trials (NCI-MATCH and TAPUR) are a group of research clinical trials involving patients with tumors that contain specific genetic mutations. These patients receive drugs directed toward their specific mutation, regardless of the type of cancer they have.

Participants in clinical trials may receive treatments not yet available to everyone. They also receive extra follow-up care in addition to their standard care. Taking part in the search for new and better cancer treatments can be personally satisfying, as participants become part of the advancement of medicine.

Every clinical trial has inclusion and exclusion restrictions that a patient must meet before enrolling in the trial. Before you decide to take part, doctors and clinical trial coordinators tell you all the known risks.

Cooperative group (NCTN) clinical trials are studies designed by a consortium of leading national cancer researchers. The goal of these studies is to test the newest and most cutting-edge innovations.

Participants in clinical trials may receive treatments not yet available to everyone. They also receive extra follow-up care in addition to their standard care. Taking part in the search for new and better cancer treatments can be personally satisfying, as participants become part of the advancement of medicine.

Every clinical trial has inclusion and exclusion restrictions that a patient must meet before enrolling in the trial. Before you decide to take part, doctors and clinical trial coordinators tell you all the known risks.

Chemoradiotherapy combines the use of chemotherapy and radiation at the same time. When given together, the two treatments are more effective than when given in sequence. This approach is often used when a cancer is advanced but has not spread to distant parts of the body and therefore may respond to more intense therapy.

Chemotherapy is the systemic use of cytotoxic chemicals to kill cancer cells. Today there are many medications (e.g., biological medications, immune treatments, targeted therapies) that do not fit the classic definition of chemotherapy yet are often included in this category.

Immunotherapy uses drugs to allow the body’s own immune system to more effectively find and destroy cancer cells.

Surgical therapies involve an operation or procedure to remove cancer from the body. Surgery may be the main treatment for some invasive cancers, but it’s only one part of the entire treatment plan. Surgical therapies include:

Robotic abdominal perineal resection is an advanced, video camera-assisted surgery to remove the rectum, anus and parts of the lower intestines.

Radiation therapy uses high-energy radiation from a source like X-rays or photons to kill cancer cells or shrink tumors. It may be part of a treatment plan that also includes systemic therapies and/or surgery. Radiation is sometimes used to help ease a patient’s pain or discomfort. Radiation therapies include:

Intensity-modulated radiation therapy (IMRT) and volumetric-modulated arc therapy (VMAT) are advanced types of radiation therapies. IMRT uses advanced technology to manipulate the radiation beams to conform to the shape of a tumor. VMAT is a subtype of IMRT in which the machine actively delivers radiation beams while moving in an arc around the patient.

This method of radiation delivery offers next-generation capabilities. The arc-based therapy provided via VMAT delivers high doses of radiation to more focused areas, reducing side effects and the overall treatment time for the patient. This treatment is particularly effective at treating several types of cancer while at the same time reducing toxicity and harm to vital organs.

This procedure is one of several new ways to deliver radiation therapy. It requires a sophisticated facility and equipment, along with highly specialized physicians. It is available at some Providence locations.

Radiopharmaceuticals (Y-90) is a group of treatments delivered by a catheter and consisting of millions of microscopic, radioactive microspheres that are infused into the arteries that feed the tumor. Y-90 microspheres are delivered into the arteries and can be used to treat cancer that has spread, or metastasized, to the liver. These particles become embedded into the cancer cells and deliver the radiation directly to the cancer site. Two commonly used agents are Theraspheres and Sir Spheres.

The advantage of this treatment is that the radiation penetrates only a short distance, so the risk to the organ is very low while the dose the cancer experiences is very high.

This procedure is one of several new ways to deliver radiation therapy directly into the tumor site. It requires a sophisticated facility and equipment, along with highly specialized physicians. It is available at some Providence locations.

Stereotactic radiation (SABR/SBRT) is a group of treatments that includes stereotactic body radiation therapy (SBRT) and stereotactic ablative radiation (SABR) – both of which are adaptations of stereotactic radiosurgery (SRS) – for the treatment of targets in the body, but outside the brain. Similar to SRS, these techniques deliver very high doses of radiation using sophisticated motion management and patient immobilization techniques.

The number of radiation treatments is minimal and may range from one to five treatments delivered over one to two weeks.

This procedure is one of several new ways to deliver radiation therapy. It requires a sophisticated facility and equipment, along with highly specialized physicians. It is available at some Providence locations.

Surface-guided radiation therapy (SGRT/SIGRT) is an approach to radiation targeting that offers real-time beam guidance from face and body surface-recognition systems.

This treatment is particularly effective at treating several types of cancer while at the same time reducing toxicity and harm to vital organs, thus minimizing side effects.

This advanced procedure requires a sophisticated facility and equipment, along with highly specialized physicians. It is available at some Providence locations.

Three-dimensional conformal radiation therapy (3DCRT) is a radiation planning and treatment technique in which three-dimensional (3D) imaging enables improved targeting for radiation treatment. 3D planning with CT imaging makes radiation treatment much more conformal, or tailored to the target.

Additional therapies may also be part of the treatment plan for a small number of patients. These may include:

Interventional radiology is an invasive procedure guided by radiologic imaging. This approach may be used to implant a port, or vascular access device, in order to obtain diagnostic material, remove fluid from the chest or abdomen, or deliver treatment locally.

Find Anal Cancer Care Close to You

Accreditations

We are proud to see our dedication to our cancer patients recognized by some of the most well-respected programs and institutions in the United States. Providence Cancer Institute’s Rectal Cancer Program is among the first 25 in the nation and the first in the Pacific Northwest to earn accreditation from the National Accreditation Program for Rectal Cancer. Several of our Providence locations have achieved these accreditations:

Meet the Team

At Providence, you'll have access to a vast network of dedicated and compassionate providers who offer personalized care by focusing on treatment, prevention and health education.